| MSFT | 6.22% | 371.03 | -0.46% | 1,116 | |
| LLY | 6.10% | 916.42 | +1.48% | 501 | |
| ABT | 5.68% | 104.83 | +0.74% | 3,899 | |
| JPM | 5.60% | 295.52 | +1.07% | 1,583 | |
| BEPC | 5.42% | 39.82 | +1.23% | 11,455 | |
| NEE | 5.42% | 91.21 | -0.45% | 5,524 | |
| CME | 4.76% | 293.93 | -2.89% | 1,496 | |
| OWL | 4.57% | 9.03 | +0.78% | 26,964 | |
AstraZeneca PLC ADR | - | 4.30% | - | - | 4,098 |
| ABBV | 3.94% | 207.18 | +0.96% | 1,531 |
CIBC U.S. High Dividend Covered Call ETF is an exchange traded fund launched and managed by CIBC Asset Management Inc. The fund is co-managed by CIBC Private Wealth Advisors, Inc. It invests in public equity markets of the United States. It invests directly and through derivatives in stocks of companies operating across diversified sectors. The fund uses derivatives such as options to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalization. The fund invests in dividend paying stocks of companies. The fund employs fundamental and quantitative analysis to create its portfolio. It seeks to benchmark the performance of its portfolio against the Dow Jones U.S. Dividend 100 Index (USD). CIBC U.S. High Dividend Covered Call ETF was formed on August 25, 2025 and is domiciled in Canada.